NCT04842955View on ClinicalTrials.gov

Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Alzheimer Disease
Interventions
DEVICE

Gamma tACS (40 Hz) over the superior parietal cortex

Single session of gamma tACS (40 Hz) over the superior parietal cortex

DEVICE

Sham tACS over the superior parietal cortex

Single session of sham tACS over the superior parietal cortex

Trial Locations (1)

25100

AO Spedali Civili, Brescia

All Listed Sponsors
lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

NCT04842955 - Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD) | Biotech Hunter | Biotech Hunter